StockData
Protagenic Therapeutics, Inc.new logo

Protagenic Therapeutics, Inc.new (PTIX) stock

PTIXOTCPharmaceutical PreparationsFiscal year ends March 31
Financials through Q1 FY2027, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 6, 2026
$0.75+0.00 (0.00%)

Close on Oct 19, 2026Market cap $1.36MP/E –Yield –

Protagenic Therapeutics, Inc.new r&d expenses

Research and development expenses are spending on new products and technology.

Protagenic Therapeutics, Inc.new's R&D Expenses for the twelve months ending Dec 31, 2024 was $3.84M, up 25.5% year over year. For fiscal 2024 it was $3.84M, up 25.5% from the year before. The highest annual figure on record is $3.84M in fiscal 2024.

Annual r&d expenses

PeriodPeriod endValueChange
FY2024Dec 31, 2024$3.84M+25.5%
FY2023Dec 31, 2023$3.06M+92.8%
FY2022Dec 31, 2022$1.59M+39.8%
FY2021Dec 31, 2021$1.14M+62.4%
FY2020Dec 31, 2020$699.80K-13.4%
FY2019Dec 31, 2019$807.95K-8.3%
FY2018Dec 31, 2018$881.19K+22.8%
FY2017Dec 31, 2017$717.45K+71.7%
FY2016Dec 31, 2016$417.87K+894.9%
FY2014Jun 30, 2014$42.00K–

Quarterly r&d expenses

Change is against the same quarter a year earlier.

Periods
PeriodPeriod endValueChange
Q1 FY2027CQ1 2026Jun 30, 2026$109.93K-92.5%
Q4 FY2024CQ4 2024Dec 31, 2024$134.58K-86.7%
Q3 FY2024CQ3 2024Sep 30, 2024$16.96K-98.5%
Q2 FY2024CQ2 2024Jun 30, 2024$19.14K-97.1%
Q1 FY2024CQ1 2024Mar 31, 2024$1.46M+319.7%
Q4 FY2023CQ4 2023Dec 31, 2023$1.01M+292.9%
Q3 FY2023CQ3 2023Sep 30, 2023$1.12M+124.2%
Q2 FY2023CQ2 2023Jun 30, 2023$671.17K+318.1%
Q1 FY2023CQ1 2023Mar 31, 2023$348.03K-48.0%
Q4 FY2022CQ4 2022Dec 31, 2022$257.52K+75.7%
Q3 FY2022CQ3 2022Sep 30, 2022$501.37K+94.9%
Q2 FY2022CQ2 2022Jun 30, 2022$160.52K+14.2%
Q1 FY2022CQ1 2022Mar 31, 2022$669.84K+13.1%
Q4 FY2021CQ4 2021Dec 31, 2021$146.57K+248.5%
Q3 FY2021CQ3 2021Sep 30, 2021$257.28K-52.3%
Q2 FY2021CQ2 2021Jun 30, 2021$140.59K+170.3%
Q1 FY2021CQ1 2021Mar 31, 2021$592.35K+798.1%
Q4 FY2020CQ4 2020Dec 31, 2020$42.06K-91.9%
Q3 FY2020CQ3 2020Sep 30, 2020$539.77K+1632.6%
Q2 FY2020CQ2 2020Jun 30, 2020$52.01K-58.5%
Q1 FY2020CQ1 2020Mar 31, 2020$65.96K-51.3%
Q4 FY2019CQ4 2019Dec 31, 2019$516.12K+166.3%
Q3 FY2019CQ3 2019Sep 30, 2019$31.15K-80.9%
Q2 FY2019CQ2 2019Jun 30, 2019$125.26K-62.5%
Q1 FY2019CQ1 2019Mar 31, 2019$135.41K-28.9%
Q4 FY2018CQ4 2018Dec 31, 2018$193.84K-37.0%
Q3 FY2018CQ3 2018Sep 30, 2018$163.07K+8.3%
Q2 FY2018CQ2 2018Jun 30, 2018$333.86K+177.8%
Q1 FY2018CQ1 2018Mar 31, 2018$190.41K+37.2%
Q4 FY2017CQ4 2017Dec 31, 2017$307.84K+288.5%
Q3 FY2017CQ3 2017Sep 30, 2017$150.62K+35.9%
Q2 FY2017CQ2 2017Jun 30, 2017$120.18K-58.6%
Q1 FY2017CQ1 2017Mar 31, 2017$138.81K+186.1%
Q4 FY2016CQ4 2016Dec 31, 2016$79.23K+890.4%
Q3 FY2016CQ3 2016Sep 30, 2016$110.82K+1008.2%
Q2 FY2016CQ2 2016Jun 30, 2016$290.58K–
Q1 FY2016CQ1 2016Mar 31, 2016$48.52K–
Q3 FY2014CQ1 2014Mar 31, 2014$8.00K–
Q2 FY2014CQ4 2013Dec 31, 2013$10.00K–

More Protagenic Therapeutics, Inc.new figures

See a number that looks wrong?